Detailed view for Smp_181040

Basic information

TDR Targets ID: 286759
Schistosoma mansoni, hypothetical protein
Source Database / ID:  GeneDB

pI: 8.1646 | Length (AA): 658 | MW (Da): 75991 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1

Druggability Group : DG1

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF12309   KIF-1 binding protein C terminal

Gene Ontology

Mouse over links to read term descriptions.
No GO information for this protein.

Metabolic Pathways

This gene is not mapped to any metabolic pathway in KEGG.

Structural information

Modbase 3D models:

There are 3 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
5 658 2x19 (B) 160 811 10.00 0 0.34 1.02032 0.2
6 658 2q5d (B) 183 860 13.00 0 0.77 1.0178 0.75
69 185 1na0 (A) 9 123 4.00 0.00000004 0 0.255612 -0.62

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

No expression data available for this gene

Orthologs

Ortholog group members (OG5_131902)

Species Accession Gene Product
Dictyostelium discoideum DDB_G0282223   hypothetical protein
Drosophila melanogaster Dmel_CG14043   CG14043 gene product from transcript CG14043-RA
Echinococcus granulosus EgrG_000409600   KIF1 binding protein
Echinococcus multilocularis EmuJ_000409600   KIF1 binding protein
Homo sapiens ENSG00000198954   KIAA1279
Leishmania braziliensis LbrM.25.1680   hypothetical protein, conserved
Leishmania donovani LdBPK_252200.1   KIF-1 binding protein C terminal, putative
Leishmania infantum LinJ.25.2200   hypothetical protein, conserved
Leishmania major LmjF.25.2110   hypothetical protein, conserved
Leishmania mexicana LmxM.25.2110   hypothetical protein, conserved
Mus musculus ENSMUSG00000036955   RIKEN cDNA 2510003E04 gene
Schistosoma japonicum Sjp_0209010   KIF1-binding protein homolog, putative
Schistosoma mansoni Smp_181040   hypothetical protein
Schmidtea mediterranea mk4.000803.02   KIF1-binding protein
Schmidtea mediterranea mk4.000803.01  
Trypanosoma brucei gambiense Tbg972.3.2180   hypothetical protein, conserved
Trypanosoma brucei Tb927.3.2210   KIF-1 binding protein C terminal, putative
Trypanosoma congolense TcIL3000_3_1330   hypothetical protein, conserved
Trypanosoma cruzi TcCLB.508479.360   hypothetical protein, conserved

Essentiality

Smp_181040 has one or more orthologs with essentiality data
Gene/Ortholog Organism Phenotype Source Study
Tb927.3.2210 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.3.2210 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (6 days) alsford
Tb927.3.2210 Trypanosoma brucei no significant loss or gain of fitness in procyclic forms alsford
Tb927.3.2210 Trypanosoma brucei significant gain of fitness in differentiation of procyclic to bloodstream forms alsford
Show/Hide essentiality data references
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier Smp_181040 (Schistosoma mansoni), hypothetical protein
Title for this comment
Comment